Italian contract research organisation CROS NT has expanded into the UK and appointed Andrew MacGarvey to lead operations from its new facility in Milton Keynes.
MacGarvey has over 15 years’ experience within the pharmaceutical sector and as CROS NT’s new vice president of UK and USA operations he will be tasked with growing ties with the contract research organisation’s UK-based customers.
MacGarvey previously held senior management and director roles at multiple contract research organisation (CROs) in Europe and the US.
“I have followed the activities of CROS NT for some time,” MacGarvey said. “I am excited by the opportunity to help with the growth of the business. CROS NT are focused on customer care, something that is very important to me. I will be bringing their great service to the UK and ultimately the US.”
Verona-headquartered CROS NT’s new UK base joins its existing facilities in Italy and Augsburg, Germany.